Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Ionis Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Apr 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Ionis Pharmaceuticals Inc (IONS-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 May 2016 Thomson Reuters Stock Report 12 $25.00

Laidlaw: IONS: 1Q16: Uneventful conference call and major focus remains on progress of three lead programs

Yesterday, IONS reported 1Q16 financial results with a net loss of ($63MM) and loss/share of ($0.52). IONS ended 1Q16 with ca...

05 May 2016 Laidlaw & Company 8 $25.00

IONS.OQ - Event Transcript of Ionis Pharmaceuticals Inc conference call, May 05, 2016 / 8:00AM ET

Edited Event Transcript of IONS.OQ conference call, May 05, 2016 / 8:00AM ET Boston, May 6, 2016 (Thomson StreetEvents)...

05 May 2016 Thomson Reuters StreetEvents 9 $75.00

IONS.OQ - Event Transcript of Ionis Pharmaceuticals Inc conference call, May 04, 2016 / 10:30AM ET

Edited Event Transcript of IONS.OQ conference call, May 04, 2016 / 10:30AM ET Boston, May 6, 2016 (Thomson StreetEvents...

04 May 2016 Thomson Reuters StreetEvents 17 $75.00

IONS.OQ - Event Brief of Ionis Pharmaceuticals Inc conference call, May 04, 2016 / 10:30AM ET

Edited Event Brief of IONS.OQ conference call, May 04, 2016 / 10:30AM ET Boston, May 6, 2016 (Thomson StreetEvents) Q1...

04 May 2016 Thomson Reuters StreetEvents 15 $75.00

Laidlaw: IONS: The Kynamro chapter is closed today after the drug was out-licensed to Kastle Therapeutics

IONS announced this morning that Kastle Therapeutics has acquired the rights for developing and commercializing Kynamro for p...

03 May 2016 Laidlaw & Company 7 $25.00

Trading Report for (ISIS). A detailed report, including free correlated market analysis, and updates.

Detailed Trading Report for ISIS. Entry levels, target prices, and risk controls are integral. In addition, free market anal...

02 May 2016 Stock Traders Daily 6 $20.00

IONS: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

02 May 2016 New Constructs, LLC 10 $25.00

Thomson Reuters Stock Report - Ionis Pharmaceuticals Inc (IONS-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 May 2016 Thomson Reuters Stock Report 12 $25.00